Yıl: 2021 Cilt: 5 Sayı: 3 Sayfa Aralığı: 360 - 373 Metin Dili: İngilizce DOI: 10.14744/ejmi.2021.99063 İndeks Tarihi: 17-02-2022

The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis

Öz:
Objectives: In this study, we aimed to analyze the publications of journals in the oncology category in the last fouryears and to investigate the effects of the Covid-19 pandemic on the number of publications in oncology journals. Methods: Journals published regularly every year, and with SCImago Journal Rank indicator of at least 0.100, wereincluded in this study. A search strategy based on cancer types was created using MeSH, and the number and charac teristics of journals were recorded. Using simple linear regression, the relationship between the change in the numberof publications in countries over the years and Covid-19 was investigated. Results: 310 journals and 247,552 publications were evaluated. In 2020, the increase in the total number of publi cations was 18% compared to 2019, 19% compared to 2018, and 16% compared to 2017. When publications wereranked according to cancer types, breast cancer was the most common. When this increase is evaluated with simplelinear regression model, 21.4% of the increase compared to 2019 could be explained by the number of Covid-19 cases.(r=0.462,p=0.040). Conclusion: There was an increase in the number of publications in the field of oncology in 2020 due to the effects ofthe Covid-19 pandemic.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • 1. Lancet. Journey of a paper. Available at: https://www.thelancet.com/journey-paper. Accessed in Jan 14, 2021.
  • 2. Disis MLN. JAMA Oncology—The year in review, 2019. JAMA Oncol 2020;6:639–40. [CrossRef]
  • 3. Disis MLN. JAMA Oncology—The year in review, 2018. JAMA Oncol 2019;5:609–10. [CrossRef]
  • 4. Disis ML (Nora). JAMA Oncology—The year in review, 2017. JAMA Oncol 2018;4:632–3. [CrossRef]
  • 5. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061–9. [CrossRef]
  • 6. WHO Coronavirus Disease (COVID-19) Dashboard. Available at: https://web.archive.org/web/20210101171129/https://covid19.who.int. Accessed Jan 18, 2021.
  • 7. Gostin LO, Wiley LF. Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions. JAMA 2020;323:2137–8. [CrossRef]
  • 8. Yezli S, Khan A. COVID-19 social distancing in the Kingdom of Saudi Arabia: Bold measures in the face of political, economic, social and religious challenges. Travel Med Infect Dis 2020;37:101692. [CrossRef]
  • 9. Covid-19: France introduces 6pm curfew in hard-hit areas. Available at: https://www.france24.com/en/ europe/20210101-france-tightens-covid-19-curfew-in-worstaffected-areas. Accessed Jan 16, 2021.
  • 10. Gonçalves BT, Baiocchi G. Telemedicine and cancer research during the COVID-19 pandemic. J Surg Oncol 2021;123:359– 60. [CrossRef]
  • 11. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS med 2009;6:e1000097.
  • 12. SCImago Journal & Country Rank. Available at: http://www. scimagojr.com. Accessed Jan 2, 2021.
  • 13. Baker SR, Bloom N, Davis SJ, Terry SJ. Covid-induced economic uncertainty. National Bureau of Economic Research; 2020. Available at: https://www.nber.org/papers/w26983. Accessed Sep 6, 2021. [CrossRef]
  • 14. Kelkar AH, Cogle CR. Cancer in the time of coronavirus: a call for crisis oncology standards of care. Healthcare (Basel) 2020;8:214. [CrossRef]
  • 15. Fontana E, Arkenau HT. Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities. Cancer Treat Rev 2020;88:102047. [CrossRef]
  • 16. Thornton J. Clinical trials suspended in UK to prioritise covid-19 studies and free up staff. BMJ 2020;368:m1172. [CrossRef]
  • 17. Saini KS, de Las Heras B, Plummer R, Moreno V, Romano M, de Castro J, et al. Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms. JCO Glob Oncol 2020;6:1357–62. [CrossRef]
  • 18. Miller RC, Tsai CJ. Scholarly publishing in the wake of COVID-19. Int J Radiat Oncol Biol Phys 2020;108:491–5. [CrossRef]
  • 19. Cannistra SA, Haffty BG, Ballman K. Challenges faced by medical journals during the COVID-19 Pandemic. J Clin Oncol 2020;38:2206–7. [CrossRef]
  • 20. Chahrour M, Assi S, Bejjani M, Nasrallah AA, Salhab H, Fares M, et al. A bibliometric analysis of COVID-19 research activity: a call for increased output. Cureus 2020;12:e7357. [CrossRef]
  • 21. Gregorio-Chaviano O, Limaymanta CH, López-Mesa EK. Bibliometric evaluation of Latin American contributions on COVID-19. Biomedica 2020;40:104–15. [CrossRef]
  • 22. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
  • 23. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin 2021;71:7–33. [CrossRef]
  • 24. O’Cathail SM, Gilbert DC, Sebag-Montefiore D, Muirhead R. Challenges and consequences of COVID-19 in the management of anorectal cancer: Coming together through social distancing. Clin Oncol 2020;32:413–6. [CrossRef]
  • 25. Dharmarajan H, Anderson JL, Kim S, Sridharan S, Duvvuri U, Ferris RL, et al. Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience. Head Neck 2020;42:1310–6.
  • 26. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet 2020;395:1225–8. [CrossRef]
  • 27. Saini KS, Tagliamento M, Lambertini M, McNally R, Romano M, Leone M, et al. Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur J Cancer 2020;139:43–50.
APA iriagac Y, Çavdar E, Karaboyun K, Avci O, SEBER E (2021). The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. , 360 - 373. 10.14744/ejmi.2021.99063
Chicago iriagac Yakup,Çavdar Eyyüp,Karaboyun Kubilay,Avci Okan,SEBER Erdoğan Selçuk The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. (2021): 360 - 373. 10.14744/ejmi.2021.99063
MLA iriagac Yakup,Çavdar Eyyüp,Karaboyun Kubilay,Avci Okan,SEBER Erdoğan Selçuk The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. , 2021, ss.360 - 373. 10.14744/ejmi.2021.99063
AMA iriagac Y,Çavdar E,Karaboyun K,Avci O,SEBER E The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. . 2021; 360 - 373. 10.14744/ejmi.2021.99063
Vancouver iriagac Y,Çavdar E,Karaboyun K,Avci O,SEBER E The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. . 2021; 360 - 373. 10.14744/ejmi.2021.99063
IEEE iriagac Y,Çavdar E,Karaboyun K,Avci O,SEBER E "The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis." , ss.360 - 373, 2021. 10.14744/ejmi.2021.99063
ISNAD iriagac, Yakup vd. "The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis". (2021), 360-373. https://doi.org/10.14744/ejmi.2021.99063
APA iriagac Y, Çavdar E, Karaboyun K, Avci O, SEBER E (2021). The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. Eurasian Journal of Medical Investigation, 5(3), 360 - 373. 10.14744/ejmi.2021.99063
Chicago iriagac Yakup,Çavdar Eyyüp,Karaboyun Kubilay,Avci Okan,SEBER Erdoğan Selçuk The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. Eurasian Journal of Medical Investigation 5, no.3 (2021): 360 - 373. 10.14744/ejmi.2021.99063
MLA iriagac Yakup,Çavdar Eyyüp,Karaboyun Kubilay,Avci Okan,SEBER Erdoğan Selçuk The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. Eurasian Journal of Medical Investigation, vol.5, no.3, 2021, ss.360 - 373. 10.14744/ejmi.2021.99063
AMA iriagac Y,Çavdar E,Karaboyun K,Avci O,SEBER E The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. Eurasian Journal of Medical Investigation. 2021; 5(3): 360 - 373. 10.14744/ejmi.2021.99063
Vancouver iriagac Y,Çavdar E,Karaboyun K,Avci O,SEBER E The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis. Eurasian Journal of Medical Investigation. 2021; 5(3): 360 - 373. 10.14744/ejmi.2021.99063
IEEE iriagac Y,Çavdar E,Karaboyun K,Avci O,SEBER E "The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis." Eurasian Journal of Medical Investigation, 5, ss.360 - 373, 2021. 10.14744/ejmi.2021.99063
ISNAD iriagac, Yakup vd. "The Effects of the Covid-19 Pandemic on the Number ofPublications in Oncology Journals: A Big Data Analysis". Eurasian Journal of Medical Investigation 5/3 (2021), 360-373. https://doi.org/10.14744/ejmi.2021.99063